About Exstent Limited
Exstent Limited was founded in 2002 to develop devices that manage aortic dilation and minimise the risk of aortic dissection without the need for aortic root replacement and subsequent lifelong anticoagulant therapy.
In doing this, the company aims to make a difference to the lives of people with aortic dilatation. Our goal is to allow patients to live free from worry and without the need for anticoagulant therapy or the risk of requiring further surgery.
The people involved in Exstent Limited
Exstent Limited was founded by Tal Golesworthy. Tal was the inventor of the ExoVasc®. In 2004, he was also the first person to have the device implanted.